
Layla D. Berry
Examiner (ID: 2498, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1609, 1693, 1623, 1673 |
| Total Applications | 1717 |
| Issued Applications | 1094 |
| Pending Applications | 107 |
| Abandoned Applications | 562 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19150124
[patent_doc_number] => 11975014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/228342
[patent_app_country] => US
[patent_app_date] => 2021-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16786
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/228342 | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof | Apr 11, 2021 | Issued |
Array
(
[id] => 18348706
[patent_doc_number] => 20230136817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => TREATMENT OF ACUTE RESPIRATORY DISEASE SYNDROME (ARDS) WITH POLYSULFATED POLYSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/917904
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917904 | Treatment of acute respiratory disease syndrome (ARDS) with polysulfated polysaccharides | Apr 8, 2021 | Issued |
Array
(
[id] => 17945731
[patent_doc_number] => 20220332748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/222802
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222802
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222802 | Compounds and methods for the treatment of ocular disorders | Apr 4, 2021 | Issued |
Array
(
[id] => 17297933
[patent_doc_number] => 20210393772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => ADJUVANT AND VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/219154
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219154 | ADJUVANT AND VACCINE COMPOSITIONS | Mar 30, 2021 | Abandoned |
Array
(
[id] => 19050852
[patent_doc_number] => 20240092821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/916064
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916064 | SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS | Mar 29, 2021 | Pending |
Array
(
[id] => 16962969
[patent_doc_number] => 20210214468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHOD FOR MANUFACTURING A SHAPED CROSS-LINKED HYALURONIC ACID PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/216084
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216084 | Method for manufacturing a shaped cross-linked hyaluronic acid product | Mar 28, 2021 | Issued |
Array
(
[id] => 18071410
[patent_doc_number] => 11530233
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Beta-nicotinate ester nucleotides and processes for preparing same
[patent_app_type] => utility
[patent_app_number] => 17/216533
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 29
[patent_no_of_words] => 13089
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/216533 | Beta-nicotinate ester nucleotides and processes for preparing same | Mar 28, 2021 | Issued |
Array
(
[id] => 18725787
[patent_doc_number] => 20230340004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => PREPARATION METHOD FOR HIGH-PURITY GRANATIN A
[patent_app_type] => utility
[patent_app_number] => 17/925613
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2614
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925613
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/925613 | Preparation method for high-purity granatin A | Mar 23, 2021 | Issued |
Array
(
[id] => 17512562
[patent_doc_number] => 11291679
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-05
[patent_title] => Injectable, infusable, instillable ivermectin adjuvant for cancer therapies
[patent_app_type] => utility
[patent_app_number] => 17/208012
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3052
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208012
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208012 | Injectable, infusable, instillable ivermectin adjuvant for cancer therapies | Mar 21, 2021 | Issued |
Array
(
[id] => 17928466
[patent_doc_number] => 20220323591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => HEPARIN NANO DRUG CARRIER SYSTEM LOADED WITH AMINO ANTI-TUMOR DRUG AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/634447
[patent_app_country] => US
[patent_app_date] => 2021-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634447 | HEPARIN NANO DRUG CARRIER SYSTEM LOADED WITH AMINO ANTI-TUMOR DRUG AND PREPARATION METHOD THEREOF | Mar 20, 2021 | Abandoned |
Array
(
[id] => 17119656
[patent_doc_number] => 11130778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => CD73 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/204272
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27697
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204272 | CD73 inhibitors | Mar 16, 2021 | Issued |
Array
(
[id] => 18274622
[patent_doc_number] => 11613553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-28
[patent_title] => Methods of preparing 1'-cyano nucleosides
[patent_app_type] => utility
[patent_app_number] => 17/198829
[patent_app_country] => US
[patent_app_date] => 2021-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22065
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198829 | Methods of preparing 1'-cyano nucleosides | Mar 10, 2021 | Issued |
Array
(
[id] => 18338384
[patent_doc_number] => 20230130333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS
[patent_app_type] => utility
[patent_app_number] => 17/908176
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908176 | METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS | Mar 2, 2021 | Pending |
Array
(
[id] => 19050894
[patent_doc_number] => 20240092863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => ANTIMICROBIAL TARGET
[patent_app_type] => utility
[patent_app_number] => 17/909318
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909318 | ANTIMICROBIAL TARGET | Mar 1, 2021 | Pending |
Array
(
[id] => 17080574
[patent_doc_number] => 20210275580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF RESTLESS LEG SYNDROME (RLS)
[patent_app_type] => utility
[patent_app_number] => 17/182366
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182366 | Iron carbohydrate complex for treatment of restless leg syndrome (RLS) | Feb 22, 2021 | Issued |
Array
(
[id] => 17967040
[patent_doc_number] => 11484545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Compounds and methods for treating neurological and cardiovascular conditions
[patent_app_type] => utility
[patent_app_number] => 17/180469
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 30062
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180469 | Compounds and methods for treating neurological and cardiovascular conditions | Feb 18, 2021 | Issued |
Array
(
[id] => 18328272
[patent_doc_number] => 11633489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant
[patent_app_type] => utility
[patent_app_number] => 17/178430
[patent_app_country] => US
[patent_app_date] => 2021-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 7105
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178430 | Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant | Feb 17, 2021 | Issued |
Array
(
[id] => 18334778
[patent_doc_number] => 20230126726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => CROSSLINKED HYALURONIC ACID AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/905871
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905871
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905871 | CROSSLINKED HYALURONIC ACID AND USE THEREOF | Feb 16, 2021 | Pending |
Array
(
[id] => 16900740
[patent_doc_number] => 20210179656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/178151
[patent_app_country] => US
[patent_app_date] => 2021-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77145
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 1004
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/178151 | SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF | Feb 16, 2021 | Abandoned |
Array
(
[id] => 16868465
[patent_doc_number] => 20210161932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST
[patent_app_type] => utility
[patent_app_number] => 17/176383
[patent_app_country] => US
[patent_app_date] => 2021-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176383 | TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST | Feb 15, 2021 | Abandoned |